81 FR 75832 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 211 (November 1, 2016)

Page Range		75832-75833
FR Document		2016-26261

Federal Register, Volume 81 Issue 211 (Tuesday, November 1, 2016)

[Federal Register Volume 81, Number 211 (Tuesday, November 1, 2016)]
[Notices]
[Pages 75832-75833]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Animal Assisted Intervention 
Review.
    Date: December 5, 2016.
    Time: 8:00 a.m. to 8:00 p.m.

[[Page 75833]]

    Agenda: To review and evaluate grant applications.
    Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW., 
Washington, DC 20036.
    Contact Person: Marita R. Hopmann, Ph.D., Scientific Review 
Officer, Division of Scientific Review, National Institute of Child 
Health and Human Development, 6710B Bethesda Drive, Bethesda, MD 
20892, (301) 435-6911, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Comparative and Developmental 
Perspectives on the Emergence of Cognitive Competence.
    Date: December 7, 2016.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6710B Rockledge Drive, 
Bethesda, MD 20718 (Telephone Conference Call).
    Contact Person: Marita R. Hopmann, Ph.D., Scientific Review 
Officer, Division of Scientific Review, National Institute of Child 
Health and Human Development, 6710B Bethesda Drive, Bethesda, MD 
20892, (301) 435-6911, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: October 26, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-26261 Filed 10-31-16; 8:45 am]
BILLING CODE 4140-01-P

75832 Federal Register / Vol. 81, No. 211 / Tuesday, November 1, 2016 / Notices

DEPARTMENT OF HEALTH AND The cell line is available as live cells Advanced Technology Research Facility
HUMAN SERVICES approximately 3–4 million cells per (ATRF), 8560 Progress Drive,
sample in a T25 Flask. Auditorium Room E1600, Frederick,
National Institutes of Health Potential Commercial Applications: MD, 21702 which was published in the
• A tool to further understand fibrosis Federal Register on October 24, 2016,
Government-Owned Invention; • A tool to study granule formation, 81 FR 73119.
Availability for Licensing early mast cell development, This Notice has been amended to
AGENCY: National Institutes of Health, degranulation and chemotaxis change the: Meeting date; start and end
HHS. • Screening tool to identify target times; agenda and type of meeting. The
compounds for the treatment of meeting will now be held on November
ACTION: Notice.
pulmonary fibrosis 16, 2016 from 8:00 a.m. to November 17,
SUMMARY: The invention listed below is Competitive Advantages: 2017, 12:00 p.m. to conduct a site visit
owned by an agency of the U.S. • First progenitor mast cell line known of the Frederick National Laboratory for
Government and is available for to produce fibrotic elements Cancer Research and the National
licensing in the U.S. in accordance with • Progenitor mast cell line with rapid Cancer Institute (NCI) RAS Initiative.
35 U.S.C. 209 and 37 CFR part 404 to growth, no cytokine stimulation The meeting will be closed to the public
achieve expeditious commercialization needed. Cell doubling time of 2–3 in accordance with the provisions set
of results of federally-funded research days forth in sections 552b(c)(4) and
and development. Foreign patent 552b(c)(6), Title 5 U.S.C., as amended.
Inventors: Arnold S. Kirchenbaum The project/program and the
applications are filed on selected
and Dean D.Metcalfe, both of NIAID. discussions could disclose confidential
inventions to extend market coverage
Publications: trade secrets or commercial property
for companies and may also be available
for licensing. Kirshenbaum AS et al. such as patentable material, and
Immunophenotypic and personal information concerning
FOR FURTHER INFORMATION CONTACT:
Ultrastructural Analysis of Mast individuals associated with the project/
Licensing information may be obtained
Cells in Hermansky-Pudlak program, the disclosure of which would
by communicating with the indicated
Syndrome Type-1: A Possible constitute a clearly unwarranted
licensing contact at the Technology
Connection to Pulmonary Fibrosis.; invasion of personal privacy.
Transfer and Intellectual Property
PLoS One. 2016, Jul
Office, National Institute of Allergy and Dated: October 26, 2016.
26;11(7):e0159177, PMID 27459687
Infectious Diseases, 5601 Fishers Lane, Melanie J. Gray,
Rockville, MD 20852; tel. 301–496– Intellectual Property: HHS Reference
Program Analyst, Office of Federal Advisory
2644. A signed Confidential Disclosure No. E–270–2016/0. Available as a
Committee Policy.
Agreement will be required to receive Biological Material.
[FR Doc. 2016–26259 Filed 10–31–16; 8:45 am]
copies of unpublished scientific data. Licensing Contact: Dr. Benjamin
Hurley, (240) 669–5092, BILLING CODE 4140–01–P
SUPPLEMENTARY INFORMATION:
benjamin.hurley@nih.gov.
Technology description follows. Collaborative Research Opportunity:
The National Institute of Allergy and DEPARTMENT OF HEALTH AND
A Human Progenitor Mast Cell Line for
Infectious Diseases is seeking statements HUMAN SERVICES
Allergic and Fibrotic Research and
Therapeutic Screening of capability or interest from parties National Institutes of Health
interested in collaborative research to
Description of Technology:
further develop, evaluate or Eunice Kennedy Shriver National
Hermansky-Pudlak Syndrome type-1
commercialize this invention. Institute of Child Health & Human
(HPS-1) is a rare genetic disorder that
For collaboration opportunities, Development; Notice of Closed
affects around 1 in 500,000 people
please contact Dr. Dianca Finch; 240– Meetings
worldwide and 1 in 1,800 Puerto
669–5503, dianca.finch@nih.gov.
Ricans. Patients with HPS-1 display Pursuant to section 10(d) of the
oculocutaneous albinism, bleeding due Dated: October 26, 2016.
Federal Advisory Committee Act, as
to platelet abnormality, and pulmonary Suzanne Frisbie, amended (5 U.S.C. App.), notice is
fibrosis. Those that develop pulmonary Deputy Director, Technology Transfer and hereby given of the following meetings.
fibrosis often succumb and live no more Intellectual Property Office, National Institute The meetings will be closed to the
than a decade after early onset of of Allergy and Infectious Diseases. public in accordance with the
breathing problems. [FR Doc. 2016–26260 Filed 10–31–16; 8:45 am] provisions set forth in sections
Scientists at the National Institute of BILLING CODE 4140–01–P 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Allergy and Infectious Diseases (NIAID) as amended. The grant applications and
have developed the HPS-1 proMastocyte the discussions could disclose
(HPM) cell line, containing an HPS-1 DEPARTMENT OF HEALTH AND confidential trade secrets or commercial
mutation. This cell line resembles a HUMAN SERVICES property such as patentable material,
progenitor mast cell with reduced and personal information concerning
granule formation, significant National Institutes of Health
individuals associated with the grant
chemotactic ability, and is the first mast
asabaliauskas on DSK3SPTVN1PROD with NOTICES

National Cancer Institute; Amended applications, the disclosure of which
cell line shown to constitutively release Notice of Meeting would constitute a clearly unwarranted
cytokines, chemokines, and most invasion of personal privacy.
importantly fibrotic proteins. This cell Notice is hereby given of a change in
Name of Committee: National Institute of
line serves as a model to study granule the meeting of the Frederick National Child Health and Human Development
formation, early mast cell development, Laboratory Advisory Committee to the Special Emphasis Panel, Animal Assisted
chemotaxis and mechanisms controlling National Cancer Institute, November 16, Intervention Review.
synthesis of molecules contributing to 2016, 01:00 p.m. to November 16, 2016, Date: December 5, 2016.
fibrosis. 05:30 p.m., National Cancer Institute Time: 8:00 a.m. to 8:00 p.m.

VerDate Sep<11>2014 00:01 Nov 01, 2016 Jkt 241001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\01NON1.SGM 01NON1

Federal Register / Vol. 81, No. 211 / Tuesday, November 1, 2016 / Notices 75833

Agenda: To review and evaluate grant Dated: October 26, 2016. Laboratories Manager, Laboratories and
applications. Michelle Trout, Scientific Services Directorate, U.S.
Place: Renaissance Mayflower Hotel, 1127 Program Analyst, Office of Federal Advisory Customs and Border Protection, 1300
Connecticut Avenue NW., Washington, DC Committee Policy. Pennsylvania Avenue NW., Suite
20036. [FR Doc. 2016–26261 Filed 10–31–16; 8:45 am] 1500N, Washington, DC 20229, tel. 202–
Contact Person: Marita R. Hopmann, Ph.D., BILLING CODE 4140–01–P 344–1060.
Scientific Review Officer, Division of
Scientific Review, National Institute of Child SUPPLEMENTARY INFORMATION: Notice is
Health and Human Development, 6710B hereby given pursuant to 19 CFR 151.12
DEPARTMENT OF HOMELAND and 19 CFR 151.13, that Intertek USA,
Bethesda Drive, Bethesda, MD 20892, (301)
SECURITY Inc., 230 Crescent Ave, Chelsea, MA
435–6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of 02150, has been approved to gauge and
U.S. Customs and Border Protection
Child Health and Human Development accredited to test petroleum and
Special Emphasis Panel, Comparative and Accreditation and Approval of Intertek petroleum products for customs
Developmental Perspectives on the USA, Inc., as a Commercial Gauger purposes, in accordance with the
Emergence of Cognitive Competence. and Laboratory provisions of 19 CFR 151.12 and 19 CFR
Date: December 7, 2016. 151.13. Intertek USA, Inc., is approved
AGENCY: U.S. Customs and Border for the following gauging procedures for
Time: 10:00 a.m. to 1:00 p.m.
Protection, Department of Homeland petroleum and certain petroleum
Agenda: To review and evaluate grant
Security. products set forth by the American
applications.
Place: National Institutes of Health, 6710B ACTION: Notice of accreditation and Petroleum Institute (API):
Rockledge Drive, Bethesda, MD 20718 approval of Intertek USA, Inc., as a
(Telephone Conference Call). commercial gauger and laboratory. API chapters Title
Contact Person: Marita R. Hopmann, Ph.D., SUMMARY: Notice is hereby given, 3 ......................... Tank gauging.
Scientific Review Officer, Division of pursuant to CBP regulations, that 7 ......................... Temperature Determina-
Scientific Review, National Institute of Child Intertek USA, Inc., has been approved to tion.
Health and Human Development, 6710B gauge and accredited to test petroleum 8 ......................... Sampling.
Bethesda Drive, Bethesda, MD 20892, (301) and petroleum products for customs 12 ....................... Calculations.
435–6911, hopmannm@mail.nih.gov. purposes for the next three years as of 17 ....................... Maritime Measurements.
(Catalogue of Federal Domestic Assistance July 14, 2015.
Program Nos. 93.864, Population Research; DATES: Effective Dates: The Intertek USA, Inc., is accredited for
93.865, Research for Mothers and Children; accreditation and approval of Intertek the following laboratory analysis
93.929, Center for Medical Rehabilitation USA, Inc., as commercial gauger and procedures and methods for petroleum
Research; 93.209, Contraception and laboratory became effective on July 14, and certain petroleum products set forth
Infertility Loan Repayment Program, National 2015. The next triennial inspection date by the U.S. Customs and Border
Institutes of Health, HHS)
will be scheduled for July 2018. Protection Laboratory Methods (CBPL)
FOR FURTHER INFORMATION CONTACT: and American Society for Testing and
Approved Gauger and Accredited Materials (ASTM):

CBPL No. ASTM Title

27–04 ........................................................ D95 Standard Test Method for Water in Petroleum Products and Bituminous Materials
by Distillation.
27–06 ........................................................ D473 Standard Test Method for Sediment in Crude Oils and Fuel Oils by the Extraction
Method.
27–08 ........................................................ D86 Standard Test Method for Distillation of Petroleum Products.
27–09 ........................................................ D4953 Standard Test Method for Vapor Pressure of Gasoline and Gasoline-Oxgenate
Blends (Dry Method).
27–11 ........................................................ D445 Standard Test Method for Kinematic Viscosity of Transparent and Opaque Liquids.
27–13 ........................................................ D4294 Standard Test Method for Sulfur in Petroleum and Petroleum Products by Energy-
Dispersive X-ray Fluorescence Spectrometry.
27–48 ........................................................ D4052 Standard Test Method for Density and Relative Density of Liquids by Digital Den-
sity Meter.
27–50 ........................................................ D93 Standard Test Methods for Flash-Point by Pensky-Martens Closed Cup Tester.
27–54 ........................................................ D1796 Standard Test Method for Water and Sediment in Fuel Oils by the Centrifuge Meth-
od.
27–58 ........................................................ D5191 Standard Test Method For Vapor Pressure of Petroleum Products.
N/A ............................................................ D1319 Standard Test Method for Hydrocarbon Types in Liquid Petroleum Products by Flu-
orescent Indicator Absorption.
N/A ............................................................ D3606 Standard Test Method for Determination of Benzene and Toluene in Finished Motor
and Aviation Gasoline by Gas Chromatography.
N/A ............................................................ D4815 Standard Test Method for Determination of MTBE, ETBE, TAME, DIPE, tertiary-
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Amyl Alcohol and C1 to C4 Alcohols in Gasoline by Gas Chromatography.
N/A ............................................................ D5453 Standard Test Method for Determination of Total Sulfur in Light Hydrocarbons,
Spark Ignition Engine Fuel, Diesel Engine Fuel, and Engine Oil by Ultraviolet Flu-
orescence.

Anyone wishing to employ this entity gauger services should request and entity that it is accredited or approved
to conduct laboratory analyses and receive written assurances from the by the U.S. Customs and Border

VerDate Sep<11>2014 00:01 Nov 01, 2016 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\01NON1.SGM 01NON1

Document Created: 2016-11-01 02:36:03
Document Modified: 2016-11-01 02:36:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 5, 2016.
FR Citation		81 FR 75832

81 FR 75832 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 211 (November 1, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health